scorecardresearch
Add as a preferred source on Google
Monday, March 30, 2026
TopicGLP-1

Topic: GLP-1

‘Price no challenge, mindset is’: Novo Nordisk eyes next-gen anti-obesity drugs as generics enter market

Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.

What happens when use of GLP-1 drugs is stopped? What UK researchers found on tracking patients for a yr

Semaglutide, active ingredient in popular weight-loss drugs, including Ozempic and Wegovy, belongs to the class of medications known as GLP-1 receptor agonists.

How GLP-1 ‘wonder drugs’ for diabetes & obesity also reduce risk of addiction to liquor, smoking & more

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

On Camera

Trans Amendment Bill echoes Criminal Tribes Act. It wants them to stay in violent families

The one thing that keeps the relentless beauty of trans people alive is their community. But for lawmakers, kinship is ‘deception’, ‘allurement’, and ‘undue influence’.

Blow to West Asia commodities market as Iran hits 2 aluminium makers

Aluminum prices, already rising before the conflict, have gained further as traders and buyers focus on the potential for tighter markets and shrinking global inventories.

1st batch of 2,000 India-made Israeli Negev LMGs delivered to Army; 4,000 more to be delivered this year

The Indian Army is set to get another 4,000 of these LMGs as part of a contract signed in August 2024 to replace the 5.56x45mm INSAS LMG.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.